Renal Cancer - Results from #3660

A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma. April 16, 2019

Perinephric invasion as a prognostic factor in non-metastatic renal cell carcinoma: analysis of a nation-wide registry program. April 15, 2019

Incident Chronic Kidney Disease After Radical Nephrectomy for Renal Cell Carcinoma. April 15, 2019

Extended Duration of Active Surveillance of Small Renal Masses: A Prospective Cohort Study. April 15, 2019

The effect of a treatment delay on outcome in metastatic renal cell carcinoma. April 12, 2019

Novel Therapeutic Approaches and Targets Currently Under Evaluation for Renal Cell Carcinoma: Waiting for the Revolution. April 12, 2019

The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER? April 12, 2019

Expression of total and phospho 4EBP1 in metastatic and non-metastatic renal cell carcinoma. April 11, 2019

Risk Prediction Tool for Aggressive Tumors in Clinical T1 Stage Clear Cell Renal Cell Carcinoma Using Molecular Biomarkers. April 11, 2019

Role of Interface Sign and Diffusion-Weighted Magnetic Resonance Imaging in Differential Diagnosis of Exophytic Renal Masses. April 11, 2019

Techniques and outcomes of minimally-invasive surgery for nonmetastatic renal cell carcinoma with inferior vena cava thrombosis: a systematic review of the literature. April 10, 2019

Radiofrequency Ablation, Cryoablation and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes. April 10, 2019

Early assessment with 18F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab. April 10, 2019

Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program. April 9, 2019

An immunophenotyping of renal clear cell carcinoma with characteristics and a potential therapeutic target for patients insensitive to immune checkpoint blockade. April 9, 2019

Is Chest Computed Tomography Always Necessary Following Nephrectomy for Renal Cell Carcinoma? A Pilot Study in Single Tertiary Institution. April 9, 2019

Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup 3-year follow-up analysis from the Phase III CheckMate 025 study. April 8, 2019

Upregulation of LINC00982 inhibits cell proliferation and promotes cell apoptosis by regulating the activity of PI3K/AKT signaling pathway in renal cancer. April 8, 2019

Radiological Response and Neutrophil-to-Lymphocyte Ratio as Predictive Factors for Progression-Free and Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib. April 8, 2019

Systemic therapy in the management of localized and locally advanced renal cell carcinoma: Current state and future perspectives. April 5, 2019

Page 184 of 456